Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

Abstract Early relapse after platinum chemotherapy in epithelial ovarian cancer (EOC) portends poor survival. A‐priori identification of platinum resistance is therefore crucial to improve on standard first‐line carboplatin–paclitaxel treatment. The DNA repair pathway homologous recombination (HR) r...

Full description

Bibliographic Details
Main Authors: Michal M Hoppe, Patrick Jaynes, Joanna D Wardyn, Sai Srinivas Upadhyayula, Tuan Zea Tan, Stefanus Lie, Diana G Z Lim, Brendan N K Pang, Sherlly Lim, Joe P S Yeong, Anthony Karnezis, Derek S Chiu, Samuel Leung, David G Huntsman, Anna S Sedukhina, Ko Sato, Monique D Topp, Clare L Scott, Hyungwon Choi, Naina R Patel, Robert Brown, Stan B Kaye, Jason J Pitt, David S P Tan, Anand D Jeyasekharan
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:EMBO Molecular Medicine
Subjects:
HRD
immune exclusion
multiplexed IHC
ovarian cancer
RAD51
Online Access:https://doi.org/10.15252/emmm.202013366

Internet

https://doi.org/10.15252/emmm.202013366

Similar Items